Exclusive agreement opens a worldwide commercial channel for myriamed’s iPSC-derived cardiac cells and marks the start of the company’s international scale-up.
myriamed and SYNENTEC are proud to unveil the myrImager - a groundbreaking platform for high-content-analysis of pluripotent stem cell-derived heart muscle, skeletal muscle and connective tissue.
Can hearts and heart muscle be repaired? What role do pluripotent stem cells play in this? And how could the same technology also produce artificial flesh on a massive scale?
The text, labels and radio buttons can be customized in the file mod_cookiebar.html5. Further information about which cookies are used in the theme Eclipse can be found here: Eclipse Manual - Cookies
